BE873909A - Derives d'alkylenediamines - Google Patents

Derives d'alkylenediamines

Info

Publication number
BE873909A
BE873909A BE0/193248A BE193248A BE873909A BE 873909 A BE873909 A BE 873909A BE 0/193248 A BE0/193248 A BE 0/193248A BE 193248 A BE193248 A BE 193248A BE 873909 A BE873909 A BE 873909A
Authority
BE
Belgium
Prior art keywords
alkylenediamine derivatives
alkylenediamine
derivatives
Prior art date
Application number
BE0/193248A
Other languages
English (en)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BE873909A publication Critical patent/BE873909A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/193248A 1978-02-06 1979-02-02 Derives d'alkylenediamines BE873909A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7803175A FR2421888A1 (fr) 1978-02-06 1978-02-06 Amides d'alkylene-diamines et leur application en therapeutique
FR7836819A FR2445323A2 (fr) 1978-02-06 1978-12-29 Amides d'alkylenediamines et leur application en therapeutique

Publications (1)

Publication Number Publication Date
BE873909A true BE873909A (fr) 1979-08-02

Family

ID=26220430

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/193248A BE873909A (fr) 1978-02-06 1979-02-02 Derives d'alkylenediamines

Country Status (23)

Country Link
US (1) US4315007A (fr)
JP (1) JPS6023114B2 (fr)
AT (1) AT365176B (fr)
AU (1) AU521524B2 (fr)
BE (1) BE873909A (fr)
CA (1) CA1102330A (fr)
CH (1) CH637122A5 (fr)
DE (1) DE2904445C2 (fr)
DK (1) DK159316C (fr)
ES (1) ES477457A1 (fr)
FI (1) FI66861C (fr)
FR (2) FR2421888A1 (fr)
GB (1) GB2013679B (fr)
GR (1) GR66846B (fr)
IE (1) IE47812B1 (fr)
IL (1) IL56578A (fr)
IT (1) IT1192347B (fr)
LU (1) LU80880A1 (fr)
NL (2) NL181482C (fr)
NO (1) NO151463C (fr)
NZ (1) NZ189553A (fr)
PT (1) PT69178A (fr)
SE (1) SE449360B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466462A2 (fr) * 1978-02-06 1981-04-10 Synthelabo Derives d'alkylenediamines, leur preparation et leur application en therapeutique
DE3380093D1 (en) * 1982-09-30 1989-07-27 William John Louis 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
JPS6093016A (ja) * 1983-10-25 1985-05-24 Natl House Ind Co Ltd クランプ搬送装置
FR2570275B1 (fr) * 1984-09-14 1986-11-21 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'alfusozine
FR2577804B1 (fr) * 1985-02-26 1987-03-27 Synthelabo Compositions pharmaceutiques a base de verapamil et d'alfuzosine
FR2577803B1 (fr) * 1985-02-26 1987-04-03 Synthelabo Compositions pharmaceutiques a base de nifedipine et d'alfuzosine
EP0189336A1 (fr) * 1985-01-18 1986-07-30 Synthelabo Compositions pharmaceutiques contenant un alpha-bloquant et un antagoniste du calcium
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
LU86672A1 (fr) * 1986-11-19 1988-06-13 Oreal Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
NZ241979A (en) * 1991-03-20 1996-01-26 Merck & Co Inc Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US6313294B1 (en) 1998-02-04 2001-11-06 Development Center For Biotechnology Process for preparing amides
EP1891954A3 (fr) 1998-09-30 2009-01-14 Takeda Pharmaceutical Company Limited Agents pour améliorer le pouvoir de vidange de la vessie
WO2001068615A1 (fr) * 2000-03-13 2001-09-20 Chemrx Advanced Technologies, Inc. Synthese de la quinazoline
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
CA2451267A1 (fr) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Utilisations pharmaceutiques de ligands alpha2delta
RU2331438C2 (ru) 2002-12-13 2008-08-20 Уорнер-Ламберт Компани Ллс Альфа-2-дельта лиганд для лечения симптомов нижних мочевыводящих путей
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
PL1789412T3 (pl) * 2004-09-16 2008-10-31 Hetero Drugs Ltd Krystaliczna zasada alfuzosyny
ES2313626T3 (es) * 2005-03-21 2009-03-01 Pfizer Limited Derivados de triazol sustituidos como antagonistas de oxitocina.
WO2006100588A1 (fr) * 2005-03-21 2006-09-28 Pfizer Limited Derives de triazole substitues utilises en tant qu'antagonistes d'oxytocine
US20100222365A1 (en) * 2005-08-10 2010-09-02 Pfizer Inc Substituted triazole deriviatives as oxytocin antagonists
US20070066824A1 (en) * 2005-09-22 2007-03-22 Anumula Raghupathi R Preparation of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
CN101190890B (zh) 2006-11-30 2011-04-27 江苏豪森药业股份有限公司 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
US20080160081A1 (en) * 2006-12-11 2008-07-03 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making, and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
EP2152697A2 (fr) * 2007-05-04 2010-02-17 Actavis Group PTC EHF Procédé de préparation de l'alfuzosine et de ses sels
WO2009001369A1 (fr) * 2007-06-22 2008-12-31 Alembic Limited Procédé perfectionné pour la préparation de chlorhydrate d'alfuzosine
WO2009007987A1 (fr) * 2007-07-11 2009-01-15 Alembic Limited Procédé amélioré pour la préparation d'alfuzosine et de son nouveau polymorphe
KR20100044239A (ko) * 2007-08-02 2010-04-29 시플라 리미티드 알푸조신 염산염의 제조방법
US20090076043A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched alfuzosin
WO2010083360A2 (fr) * 2009-01-16 2010-07-22 Mutual Pharmaceutical Company, Inc. Préparations à libération contrôlée
CN107998090A (zh) * 2017-12-30 2018-05-08 威海贯标信息科技有限公司 一种阿夫唑嗪片组合物
CN113801069B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种盐酸阿夫唑嗪中间体化合物
CN114573569B (zh) * 2022-03-30 2023-07-04 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
FR2350101A1 (fr) * 1976-05-07 1977-12-02 Synthelabo Nouvelles guanidines cyclisees
FR2362630A1 (fr) * 1976-08-24 1978-03-24 Synthelabo Derives d'alkylenediamines
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
FR2389613A2 (en) * 1977-05-05 1978-12-01 Synthelabo Antihypertensive 4-amino-6,7-di:methoxy-quinazolyl alkylene di:amine - prepd. from a 2-halo-quinazoline and an alkylene di:amine

Also Published As

Publication number Publication date
NO151463B (no) 1985-01-02
GB2013679A (en) 1979-08-15
AT365176B (de) 1981-12-28
SE449360B (sv) 1987-04-27
LU80880A1 (fr) 1980-09-24
NZ189553A (en) 1981-05-01
AU4389579A (en) 1979-08-16
IE790210L (en) 1979-08-06
FI66861C (fi) 1984-12-10
FI790369A (fi) 1979-08-07
DK159316C (da) 1991-03-04
NO151463C (no) 1985-04-17
NL181482B (nl) 1987-04-01
IT7919908A0 (it) 1979-02-05
FR2445323B2 (fr) 1981-11-27
IE47812B1 (en) 1984-06-27
DK46079A (da) 1979-08-07
IL56578A (en) 1983-02-23
FI66861B (fi) 1984-08-31
AU521524B2 (en) 1982-04-08
SE7900987L (sv) 1979-08-07
JPS6023114B2 (ja) 1985-06-05
FR2421888A1 (fr) 1979-11-02
GB2013679B (en) 1982-09-02
NO790358L (no) 1979-08-07
US4315007A (en) 1982-02-09
CA1102330A (fr) 1981-06-02
NL7900917A (nl) 1979-08-08
DE2904445C2 (de) 1986-10-30
NL930043I1 (nl) 1993-08-02
IL56578A0 (en) 1979-05-31
ATA84279A (de) 1981-05-15
GR66846B (fr) 1981-05-05
PT69178A (fr) 1979-03-01
CH637122A5 (fr) 1983-07-15
JPS54117487A (en) 1979-09-12
ES477457A1 (es) 1979-10-16
DK159316B (da) 1990-10-01
FR2445323A2 (fr) 1980-07-25
NL181482C (nl) 1987-09-01
NL930043I2 (nl) 1993-11-16
FR2421888B1 (fr) 1980-09-26
IT1192347B (it) 1988-03-31
DE2904445A1 (de) 1979-08-16

Similar Documents

Publication Publication Date Title
BE873909A (fr) Derives d'alkylenediamines
FR2517303B1 (fr) Derives d'imidazole
LU80925A1 (fr) Derives de dehydrocyclicimino-acides
MC1355A1 (fr) Derives d'imidazodiazepine
BE875773A (nl) 2'deoxy-5-(halogeenvinyl)-uridines
MC1252A1 (fr) Derives de piperazine
PT70503A (fr) Derives de la phenil-1 (piperidyl-4)-3-propanone-1 utilisables comme medicaments
MC1258A1 (fr) Derives pyrrolidiniques
PT74710A (fr) Nouveaux derives d'aminoethoxy-4 isopropyl-5 methyl-2-phenol
BE864321A (fr) Derives d'acide oxazolinoazetidinylbutyrique
BE863609A (fr) Derives d'oxadiazolopyrimidine
BE877994A (fr) Derives de phenyl-1 piperazine
FI790852A (fi) Antiinflammatoriska 4,5-diaryl-2-(substituerad-tio)-pyrroler och motsvarande sufoxider och sulfoner daerav
MC1183A1 (fr) Derives d'oxadiazolopyrimidine
BE874803A (fr) Generateur d'emulsion
BE874488A (fr) Derives benzylideniques
MC1285A1 (fr) Derives d'isoquinoleine
IT1113880B (it) Induttore d'arresto
LU81071A1 (fr) Vitrai 12
IT7950202A0 (it) Derivati alfa-aril-alfa alfa-bisomega-ammino bisostituiti alchilacetammidici ditati di proprieta'farmacologiche antiaritmia
IT1116869B (it) Derivati di n-alcheni-moranolina aventi attivita'farmacologica
FI790141A (fi) 2 6-dinitrobensenaminer
MC1275A1 (fr) Derives de carbazole
MC1438A1 (fr) Derives d'oxadiazolopyrimidine
MC1278A1 (fr) Derives d'oxadiazolotriazines

Legal Events

Date Code Title Description
CCPV Grant of a supplementary protection certificate

Free format text: 096C0011, EXPIRES: 20021112

RE20 Patent expired

Owner name: SYNTHELABO

Effective date: 19990202